GB9105677D0 - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
GB9105677D0
GB9105677D0 GB919105677A GB9105677A GB9105677D0 GB 9105677 D0 GB9105677 D0 GB 9105677D0 GB 919105677 A GB919105677 A GB 919105677A GB 9105677 A GB9105677 A GB 9105677A GB 9105677 D0 GB9105677 D0 GB 9105677D0
Authority
GB
United Kingdom
Prior art keywords
heterocyclic compounds
heterocyclic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919105677A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB919105677A priority Critical patent/GB9105677D0/en
Publication of GB9105677D0 publication Critical patent/GB9105677D0/en
Priority to GB9204887A priority patent/GB2253848A/en
Pending legal-status Critical Current

Links

GB919105677A 1991-03-19 1991-03-19 Heterocyclic compounds Pending GB9105677D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB919105677A GB9105677D0 (en) 1991-03-19 1991-03-19 Heterocyclic compounds
GB9204887A GB2253848A (en) 1991-03-19 1992-03-05 Heterocyclic compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919105677A GB9105677D0 (en) 1991-03-19 1991-03-19 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
GB9105677D0 true GB9105677D0 (en) 1991-05-01

Family

ID=10691744

Family Applications (2)

Application Number Title Priority Date Filing Date
GB919105677A Pending GB9105677D0 (en) 1991-03-19 1991-03-19 Heterocyclic compounds
GB9204887A Withdrawn GB2253848A (en) 1991-03-19 1992-03-05 Heterocyclic compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9204887A Withdrawn GB2253848A (en) 1991-03-19 1992-03-05 Heterocyclic compounds

Country Status (1)

Country Link
GB (2) GB9105677D0 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2318649T3 (en) 2000-10-20 2009-05-01 EISAI R&D MANAGEMENT CO., LTD. PROCEDURE FOR PREPARATION OF DERIVATIVES OF 4-FENOXI QUINOLINAS.
JP2004517851A (en) 2000-12-27 2004-06-17 バイエル アクチェンゲゼルシャフト Indole derivatives as thyroid receptor ligands
US7186745B2 (en) 2001-03-06 2007-03-06 Astrazeneca Ab Indolone derivatives having vascular damaging activity
ATE508747T1 (en) 2003-03-10 2011-05-15 Eisai R&D Man Co Ltd C-KIT KINASE INHIBITORS
JP4303726B2 (en) 2003-11-11 2009-07-29 エーザイ・アール・アンド・ディー・マネジメント株式会社 Urea derivative and method for producing the same
EP1797881B1 (en) 2004-09-17 2009-04-15 Eisai R&D Management Co., Ltd. Medicinal composition with improved stability and reduced gelation properties
US9006240B2 (en) 2005-08-02 2015-04-14 Eisai R&D Management Co., Ltd. Method for assay on the effect of vascularization inhibitor
KR101353763B1 (en) 2005-11-07 2014-01-21 에자이 알앤드디 매니지먼트 가부시키가이샤 USE OF COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND c-kit KINASE INHIBITOR
CN101443009A (en) 2006-05-18 2009-05-27 卫材R&D管理有限公司 Antitumor agent for thyroid cancer
WO2008026748A1 (en) 2006-08-28 2008-03-06 Eisai R & D Management Co., Ltd. Antitumor agent for undifferentiated gastric cancer
CA2676796C (en) 2007-01-29 2016-02-23 Eisai R & D Management Co., Ltd. Composition for treatment of undifferentiated gastric cancer
JP5638244B2 (en) 2007-11-09 2014-12-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 Combination of angiogenesis inhibitors and antitumor platinum complexes
BR112012032462A2 (en) 2010-06-25 2016-11-08 Eisai R&D Man Co Ltd antitumor agent employing compounds which, in combination, have kinase inhibiting effect.
EP2700403B1 (en) 2011-04-18 2015-11-25 Eisai R&D Management Co., Ltd. Therapeutic agent for tumor
EP2714937B1 (en) 2011-06-03 2018-11-14 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
BR112015009004A8 (en) 2012-12-21 2021-07-20 Eisai R&D Man Co Ltd amorphous form of quinoline derivative and method of production thereof
ES2687968T3 (en) 2013-05-14 2018-10-30 Eisai R&D Management Co., Ltd. Biomarkers to predict and evaluate the reactivity of subjects with endometrial cancer to compounds with lenvatinib
HRP20221047T1 (en) 2014-08-28 2022-11-11 Eisai R&D Management Co., Ltd. High-purity quinoline derivative and method for manufacturing same
PT3263106T (en) 2015-02-25 2024-01-12 Eisai R&D Man Co Ltd Method for suppressing bitterness of quinoline derivative
WO2016140717A1 (en) 2015-03-04 2016-09-09 Merck Sharp & Dohme Corp. Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
RU2729936C2 (en) 2015-06-16 2020-08-13 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Anticancer agent
JP7125719B2 (en) * 2017-03-08 2022-08-25 国立大学法人東海国立大学機構 plant growth regulator

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790391A (en) * 1971-10-20 1973-04-20 Squibb & Sons Inc THIAZOLINYLINDOLES AND THIAZINYLINDOLES, THEIR PREPARATION AND THEIR THERAPEUTIC USES

Also Published As

Publication number Publication date
GB2253848A (en) 1992-09-23
GB9204887D0 (en) 1992-04-22

Similar Documents

Publication Publication Date Title
GB9125001D0 (en) Heterocyclic compounds
GB9204887D0 (en) Heterocyclic compounds
GB9113626D0 (en) Heterocyclic compounds
GB9205484D0 (en) Heterocyclic compounds
GB9121727D0 (en) Heterocyclic compounds
GB9205507D0 (en) Heterocyclic compounds
GB9104838D0 (en) Heterocyclic compounds
GB9104832D0 (en) Heterocyclic compounds
GB9123916D0 (en) Heterocyclic compounds
GB9106609D0 (en) Heterocyclic compounds
GB9104769D0 (en) Heterocyclic compounds
GB9111131D0 (en) Heterocyclic compounds
GB9205487D0 (en) Heterocyclic compounds
GB9117987D0 (en) Heterocyclic compounds
GB9204859D0 (en) Heterocyclic compounds
AP9200435A0 (en) Heterocyclic compounds
GB9215645D0 (en) Heterocyclic compounds
GB9116575D0 (en) Heterocyclic compounds
GB9104771D0 (en) Heterocyclic compounds
GB9121097D0 (en) Heterocyclic compounds
GB9121149D0 (en) Heterocyclic compounds
GB9121327D0 (en) Heterocyclic compounds
GB9108217D0 (en) Heterocyclic compounds
GB9123397D0 (en) Heterocyclic compounds
GB9111759D0 (en) Heterocyclic compounds